66363-43-7

Basic information

• Product Name: (2S,5R,6S)-benzyl 6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
• Synonyms: (2S,5R,6S)-benzyl 6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
• CAS NO: 66363-43-7
• Molecular Weight: 436.488
• Mol File: 66363-43-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: (2S,5R,6S)-benzyl 6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,5R,6S)-benzyl 6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(66363-43-7)
• EPA Substance Registry System: (2S,5R,6S)-benzyl 6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(66363-43-7)

Safety Data

• Hazardous Substances Data: 66363-43-7(Hazardous Substances Data)

Upstream product

• 20425-27-8 (2S,5R,6R)-6-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 
• 22509-74-6 N-ethoxycarbonylphthalimide 
• 551-16-6 6-Aminopenicillanic Acid 
• 182268-25-3 benzyl (2S)-2-[(3S,4R)-4-chloro-3-phthalimido-2-oxazetidin-1-yl]-2-(1-chlorothio-1-methylethyl)-acetate 
• 59034-26-3 (2S,5R,6R)-benzyl 6-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 
• 182268-32-2 benzyl (2S)-2-[(3R,4S)-4-chloro-3-phthalimido-2-oxazetidin-1-yl]-2-(1-chlorothio-1-methylethyl)-acetate 

Downstream Products

• 182268-25-3 benzyl (2S)-2-[(3S,4R)-4-chloro-3-phthalimido-2-oxazetidin-1-yl]-2-(1-chlorothio-1-methylethyl)-acetate 
• 1316164-16-5 benzyl (2S,5R,6S)-6-[(N-decanoyl-L-prolyl-L-threonyl-L-alanyl-L-asparaginyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylate 
• 1316164-07-4 benzyl (2S,5R,6S)-3,3-dimethyl-7-oxo-6-phthalisoimido-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 
• 1316164-02-9 2-[(2S,5R,6S)-2-(benzyloxycarbonyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-6-ylcarbamoyl]benzoic acid 
• 49626-54-2 benzyl (2S,5R,6S)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 
• 66363-44-8 benzyl α-(4β-chloro-3α-phthalimido-2-oxoazetidin-1-yl)-α-isopropylideneacetate 
• 86288-04-2 2-{(2R,3S)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-[(Z)-2-hydroxy-1-(4-nitro-benzyloxycarbonyl)-propenylsulfanyl]-4-oxo-azetidin-1-yl}-3-methyl-but-2-enoic acid benzyl ester 
• 107740-87-4 (R)-2-[(2R,3R)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-fluoro-4-oxo-azetidin-1-yl]-3-methyl-butyric acid benzyl ester 
• 107645-27-2 (R)-2-[(2R,3S)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-fluoro-4-oxo-azetidin-1-yl]-3-methyl-butyric acid benzyl ester 
• 107668-25-7 (R)-2-[(2R,3S)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-(2-methoxycarbonyl-ethanesulfinyl)-4-oxo-azetidin-1-yl]-3-methyl-but-3-enoic acid benzyl ester 
• 107668-26-8 (R)-2-[(2R,3S)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-(2-methoxycarbonyl-ethylsulfanyl)-4-oxo-azetidin-1-yl]-3-methyl-butyric acid benzyl ester 
• 107645-26-1 (R)-2-[(2R,3S)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-(2-methoxycarbonyl-ethylsulfanyl)-4-oxo-azetidin-1-yl]-3-methyl-but-3-enoic acid benzyl ester 
• 100163-33-5 2-{(2R,3S)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-[(Z)-2-hydroxy-1-(4-nitro-benzyloxycarbonyl)-propenylsulfanyl]-4-oxo-azetidin-1-yl}-3-methyl-but-2-enoic acid benzyl ester 
• 85646-92-0 2-[(2R,3S)-1-(1-Benzyloxycarbonyl-2-methyl-propenyl)-3-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-4-oxo-azetidin-2-ylsulfanyl]-malonic acid bis-(4-nitro-benzyl) ester 

Relevant articles and documents

PEPTIDE ANTIBIOTICS AND METHODS OF USE THEREOF

The invention features peptide antibiotic compositions and methods of using such compositions for the treatment of bacterial infections (e.g., vancomycin resistant infections).

Syntheses of (6S)-cephalosporins from 6-aminopenicillanic acid

Two practical routes to (6S,7S)-cephalosporins from 6-aminopenicillanic acid (6-APA) are described. In the first, 6-APA was converted to (2S,4S,5S,6S)-penicillin sulfoxide 49, which underwent Morin ring expansion to a protected (6S,7S)-cephem 50. In the s

4-FLUOROAZETIDINONE DERIVATIVES FROM SECOPENICILLANATE SULPHONIUM TETRAFLUOROBORATES

Reaction of certain secopenicillanate esters with trimethyloxonium tetrafluoroborate yielded 4-fluoroazetidinone derivatives presumably via the intermediacy of secopenicillanate sulphonium tetrafluoroborate salts.